Clinical Trial Update: Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial of recombinant human IGF-1 for short stature due to IGF-1 deficiency has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders
• Insulin-like Growth Factor Deficiency

Drugs mentioned

• rhIGF-1 (insulin-like growth factor-1)

Snippet

Sponsor: Ipsen | Conditions: Insulin-Like Growth Factor-1 Deficiency, Growth Disorders | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2010-04-15